Latest news with #medicalinnovation
The Independent
3 days ago
- Health
- The Independent
New breast cancer test predicts if disease could return
A new test has been developed to predict whether breast cancer is likely to return just two weeks after treatment begins. Experts suggest this innovation could spare thousands of breast cancer patients from receiving unnecessary treatment. The test targets oestrogen receptor-positive, human epidermal growth factor receptor 2 positive breast cancer, a type accounting for around 200,000 global cases annually. Developed by scientists at The Institute for Cancer Research, London, the test identifies the 6 per cent of patients at highest risk of relapse. The findings aim to facilitate more precise and personalised treatment plans, guiding doctors on which patients need more intensive therapy.
Yahoo
15-07-2025
- Health
- Yahoo
A mom donated her uterus to help another woman carry a baby—now they've met the child they made possible
When Emma Dolzal finally cradled her newborn daughter, Olivia, in her arms, her joy was matched by something even more profound—across from her sat Sara Leister, the woman whose selfless gift made that moment possible. Sara had donated her uterus so that Emma, who was born without one, could experience pregnancy. And now, for the first time, they were meeting face to face—with Olivia nestled between them. Their story opens a window into a rarely seen side of motherhood. It's about bold medical innovation, the quiet strength of women who've been told 'no,' and the life-changing impact of one woman lifting another up in the most intimate way imaginable. Emma Dolzal spent most of her life believing she would never carry a child. Born without a uterus due to a rare condition called MRKH syndrome, she had long grieved a version of motherhood that felt forever out of reach. Then she heard about a clinical trial at Penn Medicine offering uterine transplants—something that once seemed like science fiction. She applied. She hoped. And eventually, she became pregnant. But behind that miracle was another mother: Sara Leister, a 40-year-old nurse and mom of two, who had seen a news segment about uterine transplants and felt an immediate pull. Her own family was complete, but the thought that her uterus could help another woman experience pregnancy stayed with her. So she stepped forward, volunteered, and gave away the organ that had once carried her children. Their lives—once completely separate—were now intertwined in the most intimate way possible. Emma was able to carry and deliver a baby girl, Olivia, thanks to Sara's gift. And when the two women finally met for the first time, holding the baby they had both made possible, the gratitude between them was unmistakable. Related: First baby born after successful uterus transplant in America When Emma and Sara finally met in person, it wasn't in a hospital or a clinical setting. It was a room filled with emotion, with baby Olivia, wide-eyed and unaware of the miracle she represents, nestled between them. They smiled through tears, hugged like old friends, and marveled at the child who connected their lives in such an unexpected, profound way. Olivia arrived thanks to medicine, yes—but also because of trust, timing, and a generosity beyond what most of us ever experience. There was no need for big speeches. Just gratitude. Emma looked at Sara and saw the person who made it all possible. Sara looked at Olivia and saw the child she somehow always believed would come from her gift. 'I'm just so happy right now,' Emma told WGAL8, holding back tears.'To see her… it's just beautiful.' For a long time, Emma wasn't sure this day would ever come. And for Sara, this moment affirmed everything she had hoped her donation would mean. Related: A womb transplant between sisters led to this history-making birth—and new hope for families everywhere Until recently, women born without a uterus had few options if they wanted to become parents. Adoption, surrogacy, and gestational carriers were paths forward—but carrying their own child wasn't one of them. That's starting to change. Uterine transplant is a new and evolving medical procedure that offers hope to women with uterine factor infertility (UFI)—a condition that affects around 1 in every 500 women. The surgery involves transplanting a healthy uterus into a recipient who does not have one, followed by IVF and, if successful, a full-term pregnancy. Penn Medicine is one of the few places in the country leading this breakthrough. As of now, eight babies—including Olivia—have been born through its program. And after years in clinical trial, the procedure is now available to qualifying patients outside of the research phase. Still, it's not an easy road. The process involves complex surgeries, hormone therapy, IVF cycles, and careful monitoring. Costs are high, and not all insurance plans cover the procedure—though that's slowly beginning to change as awareness grows. What was once unimaginable is now a real, if challenging, option. And with each successful birth, the medical world moves one step closer to making it more accessible. Sara's gift went beyond the physical; she offered someone the chance at a new beginning. Her decision to donate her uterus came after her own years of motherhood were complete. But for Emma, that gift meant the chance to carry a child, feel the kicks, go through labor, and finally hold her baby in her arms. It's not a kind of donation people talk about often. Blood, kidneys, bone marrow—those are more familiar. But uterus donation? It's a quieter, less understood act of generosity that sits at the intersection of medicine, motherhood, and meaning. Sara's story opens a door—for Emma, and for other women who may now see uterus donation as a way to give back. It's a form of reproductive solidarity that speaks to something deeply maternal: the instinct to nurture, even if it's for someone else's child. 'I will tell [Olivia] that Sara made this possible for us,' Emma told WGAL8, 'That's one of the first things I'll tell her.' Their story is rare, yes—but it doesn't have to be. With growing awareness, more donors may come forward. And more women who've been told 'you'll never carry' may finally get to hear 'yes, you can.' Related: A woman born without a uterus just gave birth Emma and Sara's journey is personal, but its impact reaches far beyond their lives. For every woman born without a uterus—or who lost hers to illness or surgery—this story signals something powerful: the path to motherhood is evolving. Uterine transplant is still new. It's still complicated. But it exists. And for many, just knowing this option is real can spark hope where there once was none. It gives language to a kind of grief many women carry silently, and a possibility they may never have imagined. It also challenges our idea of what motherhood looks like. One woman carried the baby. One woman made that possible. Both are mothers in every sense of the word. This story expands what family, identity, and connection can mean—through science, through compassion, and through a belief in what's possible when women support one another in the most literal way. There's something deeply sisterly about it all. Two moms, connected by biology and bravery, each with their own role in a child's beginning. Every pregnancy has a story behind it—but few are quite like this. A woman gave her uterus to a stranger. That stranger carried a baby who will grow up knowing she was born from two kinds of love. These stories deserve to be heard—for their power, and for the possibilities they unlock. They introduce new options. They remind us that motherhood doesn't always follow a straight path. If this story moved you, ask yourself: Would you ever consider donating your uterus once your family is complete? Should insurance companies be covering procedures like this? What does it mean to expand the definition of motherhood in our lifetime? There are no right or wrong answers. Just the hope that stories like Emma and Sara's will spark more conversations—and maybe even more miracles. Olivia won't remember the day her two moms met. But one day, she'll hear the story—how one woman gave, another carried, and both believed in something bigger than themselves. And maybe, when she grows up, this kind of birth won't feel rare. Maybe it will just feel like one of the many ways families are formed, with love and courage at the center. For now, she is a living reminder of what's possible—when science catches up to hope, and when women show up for each other in extraordinary ways.
Zawya
14-07-2025
- Health
- Zawya
Burjeel Hospital launches ‘Burjeel Center for Interventional Pain Management' in Dubai
RELATED TOPICS HOSPITALITY Burjeel Hospital Burjeel Equipped with state-of-the-art technology and led by a team of board-certified specialists, the center provides targeted care for chronic spine and joint pain, cancer-related pain, as well as nerve and musculoskeletal disorders Dubai: To support patients in managing pain through safe and effective treatments, Burjeel Hospital for Advanced Surgery, Dubai, has launched the Burjeel Center for Interventional Pain Management, the first dedicated center of its kind in Dubai and the Northern Emirates. Equipped with state-of-the-art technology and led by a team of board-certified specialists, the center was inaugurated in the presence of Mr. Safeer Ahamed, Co-CEO of Burjeel Holdings, and other senior officials. 'The launch of this center further strengthens our clinical capabilities and reaffirms our commitment to delivering advanced, patient-centered care. Our goal is to ensure that every individual suffering from chronic pain has access to timely, specialized care that empowers them to live better,' said Mr. Safeer Ahamed. Redefining Pain Management Led by Dr. Manish Raj, Specialist in Endoscopic Spine & Interventional Pain Medicine, the Burjeel Center for Interventional Pain Management is designed to provide expert pain management services that align with global standards. The multidisciplinary team at the center employs interventional medicine to diagnose and treat pain. These image-guided, minimally invasive procedures minimize recovery time and improve patient outcomes. Using a patient-centered approach, the center brings together experts from Endoscopic spine surgery, minimally invasive pain interventions, interventional pain medicine, physiotherapy, and oncology to deliver integrated and personalized care. Combining world-class clinical expertise with advanced technology, it plays a crucial role in diagnosing and treating chronic spine and joint pain, cancer-related pain, as well as nerve and musculoskeletal disorders. It offers innovative procedures such as endoscopic spine surgery, SI joint fusion, indirect fusion, endoscopic-assisted fusion, spinal cord stimulator, intrathecal pump and many more advanced day care pain interventions. 'At the center, we aim to provide transformative care that goes beyond temporary relief. Our multidisciplinary approach harnesses cutting-edge diagnostics and evidence-based therapies to empower patients to reclaim their lives, free from the limitations of chronic pain,' said Dr. Manish Raj. Targeted Treatments, Personalized Care Conditions treated at the center include chronic back and neck pain, sciatica, spinal stenosis, herniated discs, degenerative disc disease, osteoarthritis, failed back surgery syndrome, and vertebral fractures. Patients also receive care for diabetic or post-injury neuropathy, shingles (PHN), trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), migraines, and myofascial pain. Cancer and visceral pain, including tumor-related discomfort and chronic abdominal or pelvic pain, are managed through tailored treatment strategies. The center offers advanced pain interventions, including spinal cord and DRG stimulation for CRPS and post-surgical pain, intrathecal pump implants for targeted medication delivery in cancer and chronic cases, and regenerative therapies like PRP and prolotherapy for sports injuries or osteoarthritis. It also provides specialized nerve blocks and image-guided injections for joint, migraine, pelvic, and complex pain management. By focusing on early intervention, integrated therapies, and increasing access to specialized care, the center is poised to improve quality of life for patients across the region.
Yahoo
13-07-2025
- Business
- Yahoo
FDA Approves Intuitive Surgical's (ISRG) New Vessel Sealer Tool
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported that it has received approval from the US Food & Drug Administration (FDA) for its latest innovation in advanced energy tools for use with its multiport da Vinci systems. This new tool, called the Vessel Sealer Curved, is a fully wristed, advanced bipolar electrosurgical instrument that can seal, cut, grasp, and dissect tissue. This instrument is the first of Intuitive Surgical, Inc.'s (NASDAQ:ISRG) advanced energy instruments to get FDA approval for the transection of lymphatic vessels. A medical team performing minimally invasive surgery with a da Vinci Surgical System. Vessel Sealer Curved has a slim, curved jaw that follows the natural contours of anatomy to help improve visibility and control, especially in tight or delicate areas. It also has a mechanical blade that cuts close to the tip, making it useful for dissecting tissue. With Vessel Sealer Curved, Intuitive Surgical, Inc. (NASDAQ:ISRG) aims to offer surgeons better precision in narrow anatomical spaces for a variety of procedures. Intuitive Surgical, Inc. (NASDAQ:ISRG) is an American medical device and technology company that develops and manufactures innovative, robotic-assisted systems for physicians and hospitals to make surgery less invasive. While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
12-07-2025
- Health
- Yahoo
SciChart Wins Healthcare Tech of the Year at 2025 National Technology Awards
Recognized for Transforming Real-Time Medical Decision-Making with Precision Data Visualization LONDON, July 12, 2025 (GLOBE NEWSWIRE) -- SciChart, the world's leading provider of high-performance charting and data visualization software, has been awarded Healthcare Tech of the Year at the 2025 National Technology Awards — one of the UK's most prestigious honors for technology innovation. Run annually by National Technology News, the awards celebrate groundbreaking contributions across AI, healthtech, fintech, cybersecurity, and more. SciChart was selected from a competitive field of medtech innovators for its pivotal role in enabling real-time clinical decisions in some of healthcare's most demanding environments — from neurorehabilitation and surgical platforms to large-scale telehealth deployments. 'This award recognizes a silent but powerful revolution,' said Andrew Burnett-Thompson, CEO and Founder of SciChart. 'Medical technology is only as useful as the decisions it enables. With SciChart, we're helping clinicians and researchers around the world make faster, safer, smarter decisions — when seconds matter most.' Driving the Future of Data-Driven Care In an era where precision and speed are paramount, SciChart is redefining the possibilities for medical interfaces, driving innovation from operating rooms to rehabilitation labs and critical care dashboards. Real-Time Recovery for Motor-Impaired Patients In advanced neurorehabilitation trials, SciChart enabled real-time visualization of muscle activity, kinematic movement, and neural stimulation — all on a single interface. This allowed clinicians to align stimulation with patient motion dynamically, contributing to patients regaining voluntary movement within days. Advanced Imaging and Diagnostics For cutting-edge clinical applications like ultrafast laser data and fluorescence capture, SciChart slashed rendering delays from 20 minutes to under 2 seconds. This unparalleled speed empowers surgeons to make immediate intraoperative decisions using live feedback and AI-generated signal analysis. 'SciChart delivered the speed and performance we needed to handle complex, high-resolution medical data — something our previous tools just couldn't keep up with.' – Head of Innovation, Surgical Technology Company Scalable Telehealth Across 5,000+ Patients One of the world's leading medical technology providers deployed SciChart to power real-time patient monitoring across 25 hospitals — enabling clinicians to respond faster to critical events and improving care for over 5,000 patients daily. Custom dashboards enabled clinicians to spot anomalies instantly, while streamlined workflows improved operational efficiency across hospital networks. Powering the Interface Between AI and Action As AI reshapes diagnostics and intervention, it creates a new challenge: delivering insights in real time, clearly and reliably. SciChart provides the high-performance visualization layer that bridges the gap between algorithmic output and clinical action — enabling live, data-rich user interfaces in surgery, diagnostics, and remote care. Unlike generic charting libraries, SciChart is purpose-built specifically for demanding, real-time medical applications, seamlessly transforming abstract data into clinically actionable insights. From live kinematic visualizations to fluorescence overlays, SciChart is the silent engine behind the next generation of healthcare technology. About SciChart Founded in 2010, SciChart provides the world's fastest, most flexible data visualization libraries. Trusted across industries where performance is paramount — including healthcare, finance, energy, and scientific research — SciChart empowers critical decision-making. Learn more at Press ContactAlicja RadwanskaChief Marketing Officer, SciChartalicja@ A photo accompanying this announcement is available at Videos accompanying this announcement are available at:
